REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cells

Oncogene

Volumn 22, Issue 19, 2003, Pages 2920-2925

  Oosterhoff, Josien K ^a   Penninkhof, Fred ^a   Brinkmann, Albert O ^a   Grootegoed, J Anton ^a   Blok, Leen J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

EGF signalling; Internalization; POB1; Prostate cancer; REPS2

Indexed keywords

ANDROGEN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; LUCIFERASE; PROTEIN; PROTEIN POB1; PROTEIN RALBP1; PROTEIN REPS2; RAL PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; ENDOCYTOSIS; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN DOMAIN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TPA RESPONSE ELEMENT; XENOGRAFT;

APOPTOSIS; BASE SEQUENCE; CARRIER PROTEINS; DOWN-REGULATION; GENE LIBRARY; GROWTH SUBSTANCES; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROSTATIC NEOPLASMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TUMOR CELLS, CULTURED;

EID: 0037683296     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206397     Document Type: Article

References (23)

1. Angel P, Imagawa M, Chiu R, Stein B, Imbra RJ, Rahmsdorf HJ, Jonat C, Herrlich P and Karin M. (1987). Cell, 49, 729-739.
2. Cantor SB, Urano T and Feig LA (1995). Mol. Cell. Biol., 15, 4578-4584.
3. Ceresa BP, Kao AW, Santeler SR and Pessin JE. (1998). Mol. Cell. Biol., 18, 3862-3870.
4. Chang GT, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ and Brinkmann AO. (1997). Cancer Res., 57, 4075-4081.
5. Coso OA, Chiariello M, Yu JC, Teramoto H, Crespo P, Xu N, Miki T and Gutkind JS. (1995). Cell, 81, 1137-1146.
6. Di Fiore PP and Gill GN. (1999). Curr. Opin. Cell. Biol., 11, 483-488.
7. Floyd S and De Camilli P. (1998). Trends Cell Biol., 8, 299-301.
8. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, Kim U, Chai LS, Kakati S, Arya SK and Sandberg AA. (1980). Prog. Clin. Biol. Res., 37, 115-132.
9. Ikeda M, Ishida O, Hinoi T, Kishida S and Kikuchi A. (1998). J. Biol. Chem., 273, 814-821.
10. Janssen T, Kiss R, Dedecker R, Petein M, Pasteels JL and Schulman C. (1995). Prostate, 27, 277-286.
11. Joneson T and Bar-Sagi D. (1999). Mol. Cell. Biol., 19, 5892-5901.
12. Jullien-Flores V, Dorseuil O, Romero F, Letourneur F, Saragosti S, Berger R, Tavitian A, Gacon G and Camonis JH. (1995). J. Biol. Chem., 270, 22473-22477.
13. Jullien-Flores V, Mahe Y, Mirey G, Leprince C, Meunier-Bisceuil B, Sorkin A and Camonis JH. (2000). J. Cell Sci., 113, 2837-2844.
14. Kariya K, Koyama S, Nakashima S, Oshiro T, Morinaka K and Kikuchi A. (2000). J. Biol. Chem., 275, 18399-18406.
15. Kozak M. (1987). Nucleic Acids Res., 15, 8125-8148.
16. Matsubara K, Hinoi T, Koyama S and Kikuchi A. (1997). FEBS Lett., 410, 169-174.
17. Nakashima S, Morinaka K, Koyama S, Ikeda M, Kishida M, Okawa K, Iwamatsu A, Kishida S and Kikuchi A. (1999). EMBO J., 18, 3629-3642.
18. Osada M, Tolkacheva T, Li W, Chan TO, Tsichlis PN, Saez R, Kimmelman AC and Chan AM. (1999). Mol. Cell. Biol., 19, 6333-6344.
19. Park SH and Weinberg RA. (1995). Oncogene, 11, 2349-2355.
20. Pruitt K and Der CJ. (2001). Cancer Lett., 171, 1-10.
21. Russell PJ, Bennett S and Strieker P. (1998). Clin. Chem., 44, 705-723.
22. van Steenbrugge GJ, van Uffelen CJ, Bolt J and Schroder FH. (1991). J. Steroid Biochem. Mol. Biol., 40, 207-214.
23. Vieira AV, Lamaze C and Schmid SL. (1996). Science, 274, 2086-2089.